Eton Pharmaceutcials
ETON
17 hedge funds and large institutions have $24.3M invested in Eton Pharmaceutcials in 2020 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
75% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 4
29% more capital invested
Capital invested by funds: $18.9M → $24.3M (+$5.39M)
21% more funds holding
Funds holding: 14 → 17 (+3)
18.65% more ownership
Funds ownership: 14.73% → 33.38% (+19%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$12.7M |
| 2 |
AIC
AWM Investment Company
New York
|
+$2.92M |
| 3 |
DC
Diametric Capital
Boston,
Massachusetts
|
+$2.64M |
| 4 |
PCM
Prelude Capital Management
New York
|
+$874K |
| 5 |
Renaissance Technologies
New York
|
+$212K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CWM
Centric Wealth Management
Chicago,
Illinois
|
-$202K |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
-$22.9K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$17.1K |
| 4 |
PMFA
Plante Moran Financial Advisors
Southfield,
Michigan
|
-$5.84K |
| 5 |
BlackRock
New York
|
-$2.55K |
ETON Hedge Fund Activity: Q1 2020 in Review
17 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Eton Pharmaceutcials (ETON) for Q1 2020, worth a combined $24.3M — up 29% from $18.9M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new ETON positions and 2 closed out — a net gain of 3 holders — while 7 added to existing stakes and 4 trimmed.
The largest buyer was Opaleye Management, adding an estimated $12.7M. The largest seller was Centric Wealth Management, exiting entirely with an estimated $202K sold.
- 17 institutional investors held Eton Pharmaceutcials (ETON) as of Q1 2020, up from 14 in Q4 2019.
- Funds reported $24.3M of Eton Pharmaceutcials stock for Q1 2020, up 29% quarter-over-quarter.
- 5 funds opened new Eton Pharmaceutcials positions in Q1 2020 and 2 closed out, a net change of +3 holders.
- The largest Eton Pharmaceutcials buyer in Q1 2020 was Opaleye Management, an estimated $12.7M added.
- The largest Eton Pharmaceutcials seller in Q1 2020 was Centric Wealth Management, an estimated $202K sold.
Based on aggregated 13F filings for Q1 2020.